Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 341-350 of 429 for multiple

Edit search filters
  1. A First in Man Trial for Patients With Cancer

    Rochester, MN

  2. PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic Malignancies

    Jacksonville, FL

  3. To Assess Safety, Tolerability And Efficacy Of LJN452 In Patients With Primary Bile Acid Diarrhea.

    Rochester, MN

  4. A Study To Evaluate The Efficacy And Safety Of ABBV-8E12 In Subjects With Early Alzheimer's Disease

    Jacksonville, FL

  5. Progressive Multiple Sclerosis (MS) and Paraneoplastic CNS Disorders Gait Changes

    Rochester, MN

  6. Center for Multiple Sclerosis and Autoimmune Neurology Research Procedures

    Jacksonville, FL, Rochester, MN

  7. Multiple Imaging Evaluations of the Liver, Pancreas, and Fat

    Rochester, MN

  8. A Phase 1/2 Study of MRTX0902 in Solid Tumors With Mutations in the KRAS MAPK Pathway

    Rochester, MN

  9. A Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of TRK-250 For Patients With Idiopathic Pulmonary Fibrosis

    Jacksonville, FL

  10. Safety And Tolerability Of ION337 For The Treatment Of Dravet Syndrome ON337-CS1

    Rochester, MN

.

Mayo Clinic Footer